MCH ADVISORY RESEARCHMain site ↗
Health Care

Health Care Supplies

7 companies under coverage.

Coverage

Health Care Supplies


Equity Research

Dentsply Sirona Inc (XRAY)

BUY. 12-month probability-weighted target $14 (+23% vs spot). Gross Margin explains 67% of Monte Carlo outcome variance.

XRAYEquity ResearchMonte Carlo
9 September 2026Rating: BUY · +17.4%
Equity Research

Align Technology Inc (ALGN)

HOLD. 12-month probability-weighted target $169 (+10% vs spot). P/E Multiple explains 64% of Monte Carlo outcome variance.

ALGNEquity ResearchMonte Carlo
9 September 2026Rating: HOLD · +15.0%
Equity Research

Lantheus Holdings Inc (LNTH)

HOLD. 12-month probability-weighted target $104 (+4% vs spot). P/E Multiple explains 70% of Monte Carlo outcome variance.

LNTHEquity ResearchMonte Carlo
9 September 2026Rating: HOLD · -0.2%
Equity Research

The Cooper Companies, Inc (COO)

HOLD. 12-month probability-weighted target $70 (+4% vs spot). P/E Multiple explains 67% of Monte Carlo outcome variance.

COOEquity ResearchMonte Carlo
9 September 2026Rating: HOLD · -5.4%
Equity Research

West Pharmaceutical Services Inc (WST)

HOLD. 12-month probability-weighted target $343 (+1% vs spot). P/E Multiple explains 62% of Monte Carlo outcome variance.

WSTEquity ResearchMonte Carlo
9 September 2026Rating: HOLD · -12.7%
Equity Research

Envista Holdings Corp (NVST)

HOLD. 12-month probability-weighted target $26 (-2% vs spot). Gross Margin explains 67% of Monte Carlo outcome variance.

NVSTEquity ResearchMonte Carlo
9 September 2026Rating: HOLD · -14.0%
Equity Research

Haemonetics Corporation (HAE)

SELL. 12-month probability-weighted target $79 (-24% vs spot). P/E Multiple explains 59% of Monte Carlo outcome variance.

HAEEquity ResearchMonte Carlo
9 September 2026Rating: SELL · -33.7%
MCH ADVISORY SERVICES · All research · Research, not personalised investment advicemchadvisoryservices.com ↗ · Research Standard v4 (decision-level) · Research OS ros-1.20.0 · US-listed